Market growth of Respiratory Medicine
Conference Series is hosting the 11th Annual Congress on Pulmonology & Respiratory Medicine (Respiratory-2020) during March 18-19, 2020 at Amsterdam, Netherlands. The Respiratory Conference is based on the theme "Revolutionizing Respiratory Care: Breath Well, Live Healthier.
Pulmonology is a medical specialty that deals with diseases involving the respiratory tract. Pulmonology is known as chest medicine and respiratory medicine in some countries and areas. Pulmonology is considered a branch of internal medicine and is related to intensive care medicine. Pulmonology often involves managing patients who need life support and mechanical ventilation. Pulmonologists are specially trained in diseases and conditions of the chest, particularly pneumonia, asthma, tuberculosis, emphysema, and complicated chest infections. A pulmonologist is a physician who specializes in the respiratory system. A pulmonologist works with patients facing serious or chronic breathing problems.
Why should attend???
By attending the Respiratory Congress 2020, Amsterdam, Netherlands can get the insights of:
- Recent trends & techniques of Respiratory Medicine & Critical care
- Upgrade yourself with latest innovations to optimize the treatment process of Respiratory Diseases
- Discuss the current challenges & update with future opportunities in improving respiratory care in the future era
- Assess the treatment gaps of various pulmonary & Respiratory diseases
- Update yourself with new strategies of diagnosing Sleep Apnea, Asthma & Allergy, COPD and other related diseases and define the new treatment strategies
- Review the efficacy of spirometer access of breathing pattern and to identify various disease conditions like Asthma, COPD, pulmonary fibrosis, cystic fibrosis and to optimize the non-invasive mechanical ventilation process in case of respiratory failure
Target Audience:
- Pulmonologists
- Respiratory Therapists
- Respiratory physicians
Thoracic surgeons - Respiratory disease specialists
- Allergy and Immunology
- General Medicine & Internal Medicine
- Radiologists
- Physiotherapy
- Nursing
- Behavioural Science
- Environmental and Occupational Health
- Infectious Disease
- Pediatric Pulmonary Specialists
Cardiology
Market Growth of Green Chemicals:
The global respiratory drug market size will grow by USD 17.67 billion during 2018-2022. This industry research report provides a detailed analysis of the market based on type (asthma, chronic obstructive pulmonary disease (COPD), allergic rhinitis, cystic fibrosis, idiopathic pulmonary fibrosis, and other respiratory disorders.
The increase in incidences and prevalence of respiratory disorders is driving the global respiratory drugs market. Several types of respiratory diseases such as COPD, asthma, and acute respiratory infections are on the rise causing major mortality and disease burden on patients. Moreover, respiratory diseases account for more than millions of deaths in developing countries with a high number of cases reported for children. This created the need for management and treatment of respiratory diseases, which in turn, drives the respiratory drugs market.
The respiratory care devices market is segmented into three major end-user segments hospitals, home care settings, and ambulatory care centers. In 2019, hospitals accounted for the largest market share of the market, mainly because of their financial capabilities, which allow them to purchase high-priced instruments and the availability of trained professionals to operate these instruments has ensured the high share of hospitals in this market. Home care settings are expected to witness the highest growth during the forecast period, mainly due to the development of compact and lightweight respiratory care devices that are easier to carry and operate.
Name: Angelina Gabin
Contact Number: +441821250010
Email: respiratory@europemeet.com